Lilly(LLY) - 2022 Q4 - Earnings Call Presentation

Lilly Q4 2022 Earnings Call February 2, 2023 AGENDA INTRODUCTION AND KEY RECENT EVENTS Dave Ricks, Chair and Chief Executive Officer 04 2022 FINANCIAL RESULTS Anat Ashkenazi, Chief Financial Officer R&D UPDATE Dan Skovronsky, M.D., Ph.D., Chief Scientific and Medical Officer CLOSING REMARKS Dave Ricks, Chair and Chief Executive Officer QUESTION AND ANSWER SESSION Not for promotional use 2022 Q4 EARNINGS 2 SAFE HARBOR PROVISION This presentation contains forward-looking statements that are based on managemen ...